Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bourgeat

Showing results (151-160 of 256) with videos related to

Pageof 26
Sort By:
Plos One|January 16, 2014
MR-less surface-based amyloid assessment based on 11C PiB PETLuping Zhou, Olivier Salvado, Vincent Dore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAshley G Gillman, Pierrick Bourgeat, Jurgen Fripp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChristopher C Rowe, Ishara Paranawithana, Vincent Dore, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 26, 2023
A universal neocortical mask for Centiloid quantificationPierrick Bourgeat, Vincent Doré, Christopher C Rowe, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Journal of Medicinal Chemistry|November 11, 2005
Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitorsC Robin Ganellin, Paul B Bishop, Ramesh B Bambal, et al.
Current Alzheimer Research|June 24, 2016
Alzheimer's Disease and the Early Signs of Age-Related Macular DegenerationShaun Frost, Robyn Guymer, Khin Zaw Aung, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 26

Showing results (151-160 of 256) with videos related to

Sort By:
Pageof 26
Plos One|January 16, 2014
MR-less surface-based amyloid assessment based on 11C PiB PETLuping Zhou, Olivier Salvado, Vincent Dore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAshley G Gillman, Pierrick Bourgeat, Jurgen Fripp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChristopher C Rowe, Ishara Paranawithana, Vincent Dore, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 26, 2023
A universal neocortical mask for Centiloid quantificationPierrick Bourgeat, Vincent Doré, Christopher C Rowe, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Journal of Medicinal Chemistry|November 11, 2005
Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitorsC Robin Ganellin, Paul B Bishop, Ramesh B Bambal, et al.
Current Alzheimer Research|June 24, 2016
Alzheimer's Disease and the Early Signs of Age-Related Macular DegenerationShaun Frost, Robyn Guymer, Khin Zaw Aung, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 26